The role of combined Ga-DOTANOC and 18FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors

Stefano Partelli, Maria Rinzivillo, Angela Maurizi, Francesco Panzuto, Matteo Salgarello, Vanessa Polenta, Gianfranco Delle Fave, Massimo Falconi

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: The aim of this study was to evaluate the effect of combined 68Ga and 18F-FDG PET/CT on treatment management for patients with pancreatic neuroendocrine tumor (PNET). Methods: Between January 2012 and April 2014, 49 consecutive patients with a cytologically and/or histologically proven diagnosis of PNET underwent combined 68Ga and 18FDG PET/CT on the same day. Results: The study group consisted of 21 males and 28 females with a median age of 59 years. Disease detection was achieved in 48 out of the 49 cases with 68Ga imaging, and in 36 of the 49 cases with 18FDG PET/CT. These results corresponded to sensitivities of 98% for 68Ga versus 73% for 18FDG PET/CT. Patients with NET-G1/NET-G2 had a positive68Ga and negative18FDG PET/CT in 13 cases, whereas both 68Ga and 18FDG PET/CT were positive in 27 cases. Patients with NEC-G3 were positive by both 68Ga and 18FDG PET/CT in 7 cases and positive only by 18FDG in 1 case. Another NEC-G3 patient was only positive by 68Ga PET/CT. The median Ki67 was 7% for 68Ga PET/CT-positive tumors and 10% for tumors with both 68Ga and 18FDG PET/CT positivity (p = 0.130). Half of the patients with a prevalent uptake of 18FDG (n = 7) had an NEC-G3 compared with 12% of patients with a prevalent uptake of 68Ga (p = 0.012). There were no significant differences between patients with positive 68Ga and those with positive 18FDG with regards to treatment choice. Conclusions: The association of 18FDG slightly increases sensitivity of 68Ga PET/CT alone in the diagnosis of PNET. A combined dual tracer PET/CT does not influence the choice of treatment strategy.

Original languageEnglish
Pages (from-to)293-299
Number of pages7
JournalNeuroendocrinology
Volume100
Issue number4
DOIs
Publication statusPublished - Feb 17 2014

Keywords

  • FDG
  • Gallium
  • Neuroendocrine neoplasm
  • Pancreatic neuroendocrine tumor
  • Positron emission tomography

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Fingerprint

Dive into the research topics of 'The role of combined Ga-DOTANOC and 18FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors'. Together they form a unique fingerprint.

Cite this